Clinical Trials Directory

Trials / Unknown

UnknownNCT04617366

Dynamic Individualized rTMS Based on fNIRS

Effect of Dynamic Individualized rTMS Based on fNIRS on Upper Limb Function of Stroke Patients

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
First Affiliated Hospital Xi'an Jiaotong University · Academic / Other
Sex
All
Age
40 Years – 79 Years
Healthy volunteers
Not accepted

Summary

Stroke patients do not respond well to the traditional repetitive transcranial magnetic stimulation (rTMS) strategy based on the competitive model. The studies found that the contralesional motion cortex has a compensatory effect on the realization of the motor function of the affected side-the compensatory model, and the degree of compensation will change as the function changes. The optimal neural regulation strategies under different models are opposite, so it is important to accurately evaluate which of the two models plays the leading role. And functional near-infrared spectroscopy (fNIRS) may accurately and quickly assess cortical function in order to determine the degree of participation of the contralesional motion cortex. We propose that the dynamic individualized strategy which adjust the rTMS parameters promptly based on the results of fNIRS will be better than the traditional stimulation strategy. This project will apply a blinded-assessment randomized controlled trial. The test group selects either the high-frequency rTMS to the contralesional dorsal premotor cortex (PMd) or the low-frequency rTMS to the contralesional primary motor cortex (M1) based on the lateralization index of the PMd measured by fNIRS. And the control group will always be given low-frequency rTMS to contralesional M1. The difference in the improvement of upper limb function between the two groups of patients was compared.

Conditions

Interventions

TypeNameDescription
OTHERIndividualized rTMS strategyIt will adjust the rTMS parameters based on the results of fNIRS.
OTHERTraditional rTMS strategyThe patients will always be given low-frequency rTMS to contralesional M1.

Timeline

Start date
2020-11-05
Primary completion
2023-12-31
Completion
2024-03-31
First posted
2020-11-05
Last updated
2022-02-23

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04617366. Inclusion in this directory is not an endorsement.